Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 7,090 shares at $35.99 ($256K) on 2021-05-04, disclosed to the SEC on 2021-05-06.
Open-market sale of $256k ADPT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.99 | 3,195 | $115K | 45.0% |
| 2 | $35.99 | 3,195 | $115K | 45.0% |
| 3 | $36.80 | 700 | $26K | 10.1% |
| Total | $36.07 avg | 7,090 | $256K | 100% |
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |